Analyst Research (FEB 23, 2007)

ARNA started as Buy at Lazard.
AT cut to Hold at Deutsche Bank.
BIO cut to Neutral at Baird.
C started as Overweight at JPMorgan.
CERN started as Outperform at CIBC.
CMVT raised to Outperform at RBC.
CSCD started as Buy at Merriman Curhan Ford.
CSGP cut to Neutral at Credit Suisse.
DNA target cut to $88 at FBR.
ETN raised to Outperform at Bear Stearns.
EXC raised to Buy at Citigroup.
FII raised to Buy at Goldman Sachs.
ISE raised to Outperform at Wachovia.
KND raised to Equal Weight at Lehman.
KSWS cut to Neutral at Susquehanna.
LGCY started as Buy at Stifel Nicolaus.
LLL cut to Neutral at B of A.
MCCC cut to Hold at Citigroup.
MDRX started as Sector Perform at CIBC.
MOVE cut to Hold at Deutsche Bank.
MPWR cut to Neutral at Goldman Sachs.
NEM cut to Underperform at RBC.
NEW raised to Neutral from Reduce at UBS.
NIHD cut to Hold at Citigroup.
NLC started as Neutral at Baird.
PGI raised to Buy at Roth.
QADI raised to Buy at SunTrust.
QSII started as Outperform at CIBC.
R raised to Outperform at Baird.
ROP raised to Outperform at Baird.
SKX reitr Buy at First Albany.
TCB raised to Buy at UBS.
THOR raised to Outperform at Bear Stearns.
TIF target raised to $48 at JMP.
TK cut to Peer Perform at Bear Stearns.
TKLC cut to Neutral at Merriman Curhan Ford; downgraded at Oppenheimer and Piper Jaffray too.
UCTT raised to Overweight at JPMorgan.
VITL started as Outperform at CIBC.
WDC raised to Buy at Citigroup.
XRTX raised to Buy at Citigroup.

Jon C. Ogg
February 23, 200